Otis Worldwide Corp vs GeneDx Holdings Corp — how do they compare? Otis Worldwide Corp trades at $70.61 (market cap $27.61B), while GeneDx Holdings Corp trades at $61.39 (market cap $1.83B). The key difference: Otis Worldwide Corp is far larger — about 15.1× GeneDx Holdings Corp's market cap, and Otis Worldwide Corp pays a 2.36% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| OTIS | WGS | |
|---|---|---|
Market Cap | $27.61B | $1.83B |
Sector | Industrials | Technology |
52-Week High | $100.99 | $167.51 |
52-Week Low | $69.34 | $34.51 |
Enterprise Value | $34.99B | $1.83B |
Dividend Yield | 2.36% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.
Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.
Trailing returns across standard periods
Latest headlines on both assets
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →